These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1440461)

  • 21. Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.
    Mlčoch T; Klimeš J; Fila L; Vávrová V; Skalická V; Turnovec M; Krulišová V; Jirčíková J; Zemková D; Dědečková KV; Bílková A; Frühaufová V; Homola L; Friedmannová Z; Drnek R; Dřevínek P; Doležal T; Macek M
    Eur J Health Econ; 2017 Jan; 18(1):73-82. PubMed ID: 26743971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.
    Beck EJ; Tolley K; Power A; Mandalia S; Rutter P; Izumi J; Beecham J; Gray A; Barlow D; Easterbrook P; Fisher M; Innes J; Kinghorn G; Mandel B; Pozniak A; Tang A; Tomlinson D; Williams I
    Pharmacoeconomics; 1998 Dec; 14(6):639-52. PubMed ID: 10346416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
    Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
    BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of treating osteoporotic fractures in the United Kingdom female population.
    Dolan P; Torgerson DJ
    Osteoporos Int; 1998; 8(6):611-7. PubMed ID: 10326069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost of care in cystic fibrosis.
    Shale DJ
    Thorax; 1992 Sep; 47(9):673. PubMed ID: 1440458
    [No Abstract]   [Full Text] [Related]  

  • 26. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG; Toumi I; Hemels ME
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis and the transition to adult health services.
    Hewer SC; Tyrrell J
    Arch Dis Child; 2008 Oct; 93(10):817-21. PubMed ID: 18809702
    [No Abstract]   [Full Text] [Related]  

  • 28. Hospital costs of treating haemophilic patients infected with HIV.
    Kennelly JM; Tolley KH; Ghani AC; Sabin CA; Maynard AK; Lee CA
    AIDS; 1995 Jul; 9(7):787-93. PubMed ID: 7546425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis.
    Iles R; Legh-Smith J; Drummond M; Prevost A; Vowler S
    J Cyst Fibros; 2003 Sep; 2(3):120-8. PubMed ID: 15463860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
    Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient costs in anticoagulation management: a comparison of primary and secondary care.
    Parry D; Bryan S; Gee K; Murray E; Fitzmaurice D
    Br J Gen Pract; 2001 Dec; 51(473):972-6. PubMed ID: 11766869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
    Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
    Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-inpatient costing study.
    Michael R; Piper K
    Aust Health Rev; 1991; 14(2):127-36. PubMed ID: 10116922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the costs of care for cystic fibrosis: an analysis by age and health state.
    van Gool K; Norman R; Delatycki MB; Hall J; Massie J
    Value Health; 2013; 16(2):345-55. PubMed ID: 23538187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual cost of erectile dysfunction to UK Society.
    Plumb JM; Guest JF
    Pharmacoeconomics; 1999 Dec; 16(6):699-709. PubMed ID: 10724796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire.
    Walters S; Britton J; Hodson ME
    Thorax; 1994 Apr; 49(4):300-6. PubMed ID: 8202897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficiency of the home intravenous antibiotics treatment in cystic fibrosis].
    Girón RM; Cisneros C; Nakeeb ZA; Hoyos N; Martínez C; Ancochea J
    Med Clin (Barc); 2006 Oct; 127(15):567-71. PubMed ID: 17145013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
    Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
    Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.
    Nageswaran A; Kinghorn GR; Shen RN; Priestley CJ; Kyi TT
    Int J STD AIDS; 1995; 6(5):336-44. PubMed ID: 8547414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.
    Kopciuch D; Zaprutko T; Paczkowska A; Nowakowska E
    Public Health; 2017 Jul; 148():49-55. PubMed ID: 28404533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.